{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:26:58Z","timestamp":1761632818376,"version":"build-2065373602"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503791"],"award-info":[{"award-number":["82503791"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2025.1726760","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:23:52Z","timestamp":1761632632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial: m6A methylation and cancer immunity"],"prefix":"10.3389","volume":"16","author":[{"given":"Qun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","article-title":"The role of RNA methylation in tumor immunity and its potential in immunotherapy","volume":"23","author":"Li","year":"2024","journal-title":"Mol Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2024.09.001","article-title":"Role of neoadjuvant pembrolizumab in advanced melanoma","volume":"51","author":"Amir","year":"2024","journal-title":"Semin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31313\\","article-title":"HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC","volume":"73","author":"Kim","year":"2021","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"216846","DOI":"10.1016\/j.canlet.2024.216846","article-title":"XBP1s activates METTL3\/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer","volume":"596","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"B5","doi-asserted-by":"publisher","first-page":"152368","DOI":"10.1016\/j.seminoncol.2025.152368","article-title":"Mechanistic role of FTO in cancer pathogenesis, immune evasion, chemotherapy resistance, and immunotherapy response","volume":"52","author":"Badraldin","year":"2025","journal-title":"Semin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"m(6)A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e14909","DOI":"10.1002\/advs.202414909","article-title":"H3K36me3-guided m(6)A modification of oncogenic L1CAM-AS1 drives macrophage polarization and immunotherapy resistance in hepatocellular carcinoma","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1038\/s41467-024-53997-6","article-title":"YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"217422","DOI":"10.1016\/j.canlet.2024.217422","article-title":"m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization","volume":"611","author":"Mak","year":"2024","journal-title":"Cancer Lett"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discov"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1726760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T06:23:53Z","timestamp":1761632633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1726760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":11,"alternative-id":["10.3389\/fimmu.2025.1726760"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1726760","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"article-number":"1726760"}}